Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 3 (1)

Trial Status

Completed3
Terminated1
Recruiting1
Withdrawn1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (6)

Research Network

Activity Timeline